{"id":"https://openalex.org/W1978350830","doi":"https://doi.org/10.1592/phco.28.5supp.1s","title":"Continued Challenges with the Use of Erythropoiesis\u2010Stimulating Agents in Patients with Cancer: Perspectives and Issues on Policy\u2010Guided Health Care","display_name":"Continued Challenges with the Use of Erythropoiesis\u2010Stimulating Agents in Patients with Cancer: Perspectives and Issues on Policy\u2010Guided Health Care","publication_year":2008,"publication_date":"2008-04-30","ids":{"openalex":"https://openalex.org/W1978350830","doi":"https://doi.org/10.1592/phco.28.5supp.1s","mag":"1978350830","pmid":"https://pubmed.ncbi.nlm.nih.gov/18447704"},"language":"en","primary_location":{"id":"doi:10.1592/phco.28.5supp.1s","doi":"https://doi.org/10.1592/phco.28.5supp.1s","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.28.5supp.1s","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043900680","display_name":"Rebecca B. Arbuckle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rebecca B. Arbuckle","raw_affiliation_strings":["Department of Drug Use Policy and Pharmacoeconomics, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA","Department of Drug Use Policy and Pharmacoeconomics, University of Texas M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Use Policy and Pharmacoeconomics, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Drug Use Policy and Pharmacoeconomics, University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036666367","display_name":"Niesha L. Griffith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Niesha L. Griffith","raw_affiliation_strings":["Department of Pharmacy, the Arthur G. James Cancer Hospital and Richard J. Solve Research Institute at The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, the Arthur G. James Cancer Hospital and Richard J. Solve Research Institute at The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090863919","display_name":"Lew M. Iacovelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1313334418","display_name":"Cone Health","ror":"https://ror.org/03jeg4p28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313334418"]},{"id":"https://openalex.org/I1324118502","display_name":"Moses H Cone Memorial Hospital","ror":"https://ror.org/045m9y072","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313334418","https://openalex.org/I1324118502"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lew M. Iacovelli","raw_affiliation_strings":["Department of Pharmacy, Moses Cone Health System Regional Cancer Center, Greensboro, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Moses Cone Health System Regional Cancer Center, Greensboro, North Carolina","institution_ids":["https://openalex.org/I1313334418","https://openalex.org/I1324118502"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Philip E. Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip E. Johnson","raw_affiliation_strings":["Department of Pharmacy, H. Lee Moffitt Cancer Center, Tampa, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, H. Lee Moffitt Cancer Center, Tampa, Florida","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109315667","display_name":"James A. Jorgenson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148268","display_name":"University of Utah Health Care","ror":"https://ror.org/047s7ex42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James A. Jorgenson","raw_affiliation_strings":["Department of Pharmacy, University of Utah Health Care, Salt Lake City, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, University of Utah Health Care, Salt Lake City, Utah","institution_ids":["https://openalex.org/I4210148268"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058164157","display_name":"Dwight D. Kloth","orcid":"https://orcid.org/0000-0001-7220-2830","observed_orcids":["https://orcid.org/0000-0001-7220-2830"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dwight D. Kloth","raw_affiliation_strings":["Department of Pharmacy, Fox Chase Cancer Center, Philadelphia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Fox Chase Cancer Center, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079014514","display_name":"Charles D. Lucarelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles D. Lucarelli","raw_affiliation_strings":["Department of Pharmacy, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065840778","display_name":"Raymond J. Muller","orcid":"https://orcid.org/0000-0002-4315-4160","observed_orcids":["https://orcid.org/0000-0002-4315-4160"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raymond J. Muller","raw_affiliation_strings":["Department of Pharmacy, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5043900680"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":1.9554,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.85857003,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"28","issue":"5P2","first_page":"1S","last_page":"15S"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chemotherapy-induced-anemia","display_name":"chemotherapy-induced anemia","score":0.8539999723434448},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.5059999823570251},{"id":"https://openalex.org/keywords/national-coverage-determination","display_name":"national coverage determination","score":0.8420000076293945},{"id":"https://openalex.org/keywords/medicare","display_name":"Medicare","score":0.48899999260902405},{"id":"https://openalex.org/keywords/fda-advisory-committee","display_name":"FDA advisory committee","score":0.6520000100135803},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.8159999847412109},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8889999985694885},{"id":"https://openalex.org/keywords/best-trial","display_name":"BEST trial","score":0.45500001311302185},{"id":"https://openalex.org/keywords/enhance-trial","display_name":"ENHANCE trial","score":0.9549999833106995},{"id":"https://openalex.org/keywords/pharmacists","display_name":"pharmacists","score":0.4569999873638153},{"id":"https://openalex.org/keywords/health-policy","display_name":"health policy","score":0.47200000286102295},{"id":"https://openalex.org/keywords/evidence-based-practice","display_name":"evidence-based practice","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8801316022872925},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5364670753479004},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5045777559280396},{"id":"https://openalex.org/C2776534028","wikidata":"https://www.wikidata.org/wiki/Q1141363","display_name":"Medicaid","level":3,"score":0.4825596213340759},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.47752514481544495},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.46526598930358887},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.4391579329967499},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.43585628271102905},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3949427604675293},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3581235110759735},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.3548816442489624},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35292255878448486},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.17019310593605042},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006278","descriptor_name":"Medicare","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D006291","descriptor_name":"Health Policy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006397","descriptor_name":"Hematinics","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006397","descriptor_name":"Hematinics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010595","descriptor_name":"Pharmacists","qualifier_ui":"Q000458","qualifier_name":"organization & administration","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018849","descriptor_name":"Controlled Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019317","descriptor_name":"Evidence-Based Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1592/phco.28.5supp.1s","doi":"https://doi.org/10.1592/phco.28.5supp.1s","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.28.5supp.1s","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},{"id":"pmid:18447704","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18447704","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.6499999761581421,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1971787155","https://openalex.org/W1978688198","https://openalex.org/W2002189627","https://openalex.org/W2077019700","https://openalex.org/W2107131611","https://openalex.org/W2153555594","https://openalex.org/W2159923585","https://openalex.org/W2164837040","https://openalex.org/W4214678020"],"related_works":["https://openalex.org/W2339742987","https://openalex.org/W2165317122","https://openalex.org/W2079555282","https://openalex.org/W1987386059","https://openalex.org/W2006126962","https://openalex.org/W1790486224","https://openalex.org/W2022555770","https://openalex.org/W2800749431","https://openalex.org/W2142731923","https://openalex.org/W2150874164"],"abstract_inverted_index":{"Erythropoiesis-stimulating":[0],"agents":[1],"(ESAs)":[2],"are":[3,261],"approved":[4],"as":[5],"an":[6,135],"alternative":[7],"to":[8,15,85,140,290],"blood":[9],"transfusions":[10],"for":[11,159,170,274,279],"treating":[12],"anemia":[13],"secondary":[14],"chemotherapy":[16],"in":[17,31,97,240,327],"patients":[18,98,276],"with":[19,53,99,192,229,301],"cancer.":[20,100],"Recently,":[21],"ESAs":[22,96],"have":[23,253],"been":[24],"a":[25,166,171,269],"source":[26],"of":[27,95,185,205,211,249,272,325],"controversy":[28],"and":[29,47,63,74,89,93,114,161,196,201,209,222,232,247,277,298,311,320],"confusion":[30,255],"the":[32,48,70,87,91,154,157,186,219,236,296,309,318,322,328],"oncology":[33],"community.":[34],"This":[35],"began":[36],"when":[37,107,305],"two":[38],"European":[39],"trials-the":[40],"Breast":[41],"Cancer":[42,51],"Erythropoietin":[43],"Survival":[44],"Trial":[45],"(BEST)":[46],"Advanced":[49],"Head-and-Neck":[50],"Treated":[52],"Radiotherapy":[54],"(ENHANCE)":[55],"Study-raised":[56],"safety":[57],"concerns":[58],"about":[59],"decreased":[60,117],"overall":[61,118],"survival":[62,130],"increased":[64],"venous":[65],"thromboembolic":[66],"events.":[67],"In":[68],"2004,":[69],"United":[71],"States":[72],"Food":[73],"Drug":[75],"Administration":[76],"(FDA)":[77],"convened":[78],"its":[79],"Oncologic":[80],"Drugs":[81],"Advisory":[82],"Committee":[83],"(ODAC)":[84],"review":[86],"data":[88],"reassess":[90],"risks":[92],"benefits":[94],"On":[101,147],"May":[102,148],"10,":[103],"2007,":[104,150,216],"ODAC":[105,155],"reconvened":[106],"five":[108],"trials":[109],"(BEST,":[110],"ENHANCE,":[111],"AMG-20010103,":[112],"AMG-20000161,":[113],"EPO-CAN-20)":[115],"showed":[116],"survival.":[119],"The":[120],"briefing":[121],"document":[122],"noted":[123],"that":[124],"studies":[125],"demonstrating":[126],"detrimental":[127],"effects":[128],"on":[129,178,213,295,316],"and/or":[131],"tumor":[132],"outcomes":[133],"used":[134],"unapproved":[136],"treatment":[137],"regimen":[138],"designed":[139],"maintain":[141],"hemoglobin":[142],"levels":[143],"above":[144],"12":[145],"g/dl.":[146],"14,":[149],"just":[151],"days":[152],"after":[153],"reconvened,":[156],"Centers":[158],"Medicare":[160,275],"Medicaid":[162],"Services":[163],"(CMS)":[164],"released":[165],"proposed":[167,187],"decision":[168],"memo":[169],"national":[172],"coverage":[173],"determination":[174],"(NCD)":[175],"imposing":[176],"restrictions":[177],"ESAs.":[179],"For":[180],"health":[181,257,292,303],"care":[182,258,293,304],"providers,":[183,259],"aspects":[184],"NCD":[188,221,237],"were":[189,198],"markedly":[190],"inconsistent":[191],"FDA-approved":[193,230],"ESA":[194,241],"use":[195],"generally":[197],"considered":[199],"ambiguous":[200],"unclear.":[202],"Over":[203],"objections":[204],"several":[206],"professional":[207,233],"associations":[208],"members":[210],"Congress,":[212],"July":[214],"30,":[215],"CMS":[217],"posted":[218],"final":[220],"declared":[223],"it":[224],"effective":[225],"immediately.":[226],"When":[227],"compared":[228],"labeling":[231],"society":[234],"guidelines,":[235],"revealed":[238],"differences":[239],"initiation,":[242],"dosage":[243,245],"escalation,":[244],"reduction,":[246],"definition":[248],"response.":[250],"These":[251],"discrepancies":[252,306],"generated":[254],"among":[256],"who":[260],"struggling":[262],"over":[263],"whether":[264],"they":[265],"can":[266],"feasibly":[267],"provide":[268],"dual":[270],"system":[271],"care-one":[273],"another":[278],"non-Medicare":[280],"patients-that":[281],"is":[282],"evidence":[283],"based.":[284],"With":[285],"this":[286],"supplement,":[287],"we":[288],"hope":[289],"educate":[291],"providers":[294],"issues":[297],"challenges":[299],"associated":[300],"policy-guided":[302],"exist":[307],"between":[308],"policy":[310],"evidence-based":[312],"practice;":[313],"offer":[314],"guidance":[315],"implementing":[317],"NCD;":[319],"highlight":[321],"important":[323],"role":[324],"pharmacists":[326],"process.":[329]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}